Inspire Investing’s BioTelemetry, Inc. BEAT Stock Holding History

Inspire Investing’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,472	Closed	-$250K	–	762
2020 Q4	$250K	Buy	+3,472	New	+$182K	0.06%	530
2020 Q3	–	Sell	-4,774	Closed	-$216K	–	603
2020 Q2	$216K	Buy	4,774 +245	+5%	+$11K	0.07%	411
2020 Q1	$174K	Buy	+4,529	New	+$209K	0.07%	492

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Inspire Investing's BEAT Position: Q1 2021 in Review

Inspire Investing sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 3,472 shares — an estimated $250K sold.

Inspire Investing first reported a position in BEAT in Q1 2020 and held it in 3 quarters. The position peaked at $250K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Inspire Investing reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Inspire Investing sold 3,472 BioTelemetry, Inc. shares in Q1 2021, an estimated $250K.
Inspire Investing first reported a position in BioTelemetry, Inc. in Q1 2020 and held it in 3 quarters.
Inspire Investing's BioTelemetry, Inc. position peaked at $250K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Inspire Investing's 13F filing for Q1 2021, filed 30 Apr 2021.